- Home
- EFSC vs PTGX Comparison
EFSC vs PTGX Comparison
Compare EFSC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- PTGX
- Stock Information
- Founded
- EFSC 1988
- PTGX 2006
- Country
- EFSC United States
- PTGX United States
- Employees
- EFSC N/A
- PTGX N/A
- Industry
- EFSC Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- PTGX Health Care
- Exchange
- EFSC Nasdaq
- PTGX Nasdaq
- Market Cap
- EFSC 2.0B
- PTGX 2.9B
- IPO Year
- EFSC 1999
- PTGX 2016
- Fundamental
- Price
- EFSC $55.40
- PTGX $55.06
- Analyst Decision
- EFSC Strong Buy
- PTGX Strong Buy
- Analyst Count
- EFSC 3
- PTGX 9
- Target Price
- EFSC $64.33
- PTGX $67.11
- AVG Volume (30 Days)
- EFSC 188.7K
- PTGX 1.0M
- Earning Date
- EFSC 07-21-2025
- PTGX 08-05-2025
- Dividend Yield
- EFSC 2.16%
- PTGX N/A
- EPS Growth
- EFSC 9.23
- PTGX N/A
- EPS
- EFSC 5.09
- PTGX 0.86
- Revenue
- EFSC $619,222,000.00
- PTGX $207,801,000.00
- Revenue This Year
- EFSC $14.06
- PTGX N/A
- Revenue Next Year
- EFSC $4.85
- PTGX $47.15
- P/E Ratio
- EFSC $10.89
- PTGX $64.57
- Revenue Growth
- EFSC 6.50
- PTGX N/A
- 52 Week Low
- EFSC $38.88
- PTGX $32.50
- 52 Week High
- EFSC $63.13
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- EFSC 65.00
- PTGX 64.63
- Support Level
- EFSC $54.05
- PTGX $52.16
- Resistance Level
- EFSC $55.29
- PTGX $57.18
- Average True Range (ATR)
- EFSC 1.10
- PTGX 1.85
- MACD
- EFSC 0.33
- PTGX -0.27
- Stochastic Oscillator
- EFSC 96.07
- PTGX 55.14
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.